Business Context and Reporting Period
Company: TTM Technologies, Inc. (TTMI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 15, 2026
Event: Entry into a Material Definitive Agreement to acquire Epiq Solutions.
Key Financial Metrics and Transaction Details
- Acquisition Price: $1,100,000,000 in cash (subject to working capital adjustments).
- Target: Epiq Solutions (all issued and outstanding membership interests).
- Financing Commitment: $1,100,000,000 total incremental senior secured term loans.
- Term A Incremental Facility: $300 million.
- Term B Incremental Facility: $800 million (seven-year term).
- Termination Fee: $77.0 million payable by the Buyer if the transaction fails to close due to lack of required regulatory approvals.
- Insurance: Buyer obtained a representation and warranty insurance policy for certain seller representations.
Material Changes and Conditions
This filing announces a material change in the Company's capital structure and operations via the proposed acquisition. The transaction is subject to the following conditions:
- Expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period.
- Absence of any order or injunction restraining the consummation.
- Accuracy of representations and warranties and compliance with covenants.
- Absence of a Material Adverse Effect post-agreement date.
Timeline: The agreement may be terminated if the transaction does not close by November 15, 2026, subject to automatic extension to May 15, 2027.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors has unanimously approved the acquisition. The Company will host a conference call on August 17, 2026, to discuss the transaction.
Risks and Contingencies:
- Regulatory Risk: Failure to obtain antitrust clearance could trigger a $77.0 million termination fee.
- Forward-Looking Statements: The filing contains predictions regarding future events; actual results may differ materially due to risks beyond the Company's control.
- Financing Conditions: While the Commitment Letter is in place, the closing of the Incremental Facilities is subject to terms and conditions consistent with the Purchase Agreement.
Investor Verification Checklist
- Verify the status of Hart-Scott-Rodino antitrust review and any potential regulatory delays.
- Review the full text of the Securities Purchase Agreement (Exhibit 2.1) for specific definitions of "Material Adverse Effect" and indemnification exclusions.
- Confirm the terms of the Incremental Facilities in the Commitment Letter (Exhibit 10.1), including interest rates and covenants.
- Monitor the Company's liquidity position to ensure it can cover the $77.0 million termination fee if regulatory approval is denied.
- Attend the August 17, 2026 conference call for management's strategic rationale and integration plans.